“We’ve found that it is possible to help people with schizophrenia to quit at about the same rate as the general public, even though the overall rates remain twice as high,” says study co-author Joel Goldberg, a professor of psychology in York’s Faculty of Health. “This research is good news for patients and for family members who have pressed for specialized programs to help their relatives quit smoking.”

The study is the first to examine the prevalence of smoking among schizophrenia outpatients over time. It surveyed participants at the Hamilton Program for Schizophrenia, a community-based psychiatric rehabilitation clinic, in 1995, then followed up with them in 2006.

In 1995, 63.2% of study participants identified themselves as smokers. In 2006, only 43.4% still smoked – a drop of 31%. Over the same period, the rate of smoking in the general public dropped by 27%.

Goldberg believes the decrease is due to several factors; the increased availability of specialized smoking cessation programs; general societal changes, including the restriction of smoking in hospitals and psychiatric wards; and a potential link with second-generation antipsychotic drugs.

“Nicotine may provide biological reward to the frontal systems of the brain, which are underactive in some people with schizophrenia,” Goldberg says. “We’re now wondering whether the new drugs have a role in mediating this process, and make it easier for some patients to quit smoking.”

He says ongoing research is needed, in part to correct some of the biases – even within the medical community – about the relationship between mental illness and smoking.

He recalls a time, decades ago, when he was trained to use cigarettes as a means to reward patients for their good behaviour.

“There’s still this notion that it’s not a problem," says Goldberg. "I have been told by health professionals that people with serious mental illnesses should just be left alone to smoke because it’s their only pleasure. Unfortunately, people with schizophrenia are among the last group to get help for nicotine addiction.”

Goldberg points out that quitting smoking is perhaps even more critical for those affected by severe mental illness; they’re often on social assistance and spend a large portion of their income on cigarettes.

“Disorders like schizophrenia make people vulnerable,” he says. “Anything we can do to help combat that vulnerability is a step in the right direction.”

The study, Longitudinal rates of smoking in a schizophrenia sample, was co-authored by Jessica Van Exan, a graduate student in York’s Faculty of Health. It will be published in the August issue of the journal, Tobacco Control.

Media contact:

Melissa Hughes, Media Relations, York University: 416 736 2100 x22097 / mehughes@yorku.ca

York University is the leading interdisciplinary research and teaching university in Canada. York offers a modern, academic experience at the undergraduate and graduate level in Toronto, Canada’s most international city. The third largest university in the country, York is host to a dynamic academic community of 50,000 students and 7,000 faculty and staff, as well as 200,000 alumni worldwide. York’s 11 faculties and 24 research centres conduct ambitious, groundbreaking research that is interdisciplinary, cutting across traditional academic boundaries. This distinctive and collaborative approach is preparing students for the future and bringing fresh insights and solutions to real-world challenges. York University is an autonomous, not-for-profit corporation.

-30-